Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Natco Pharma
Pharma
Roche files patent suit to fend off potential Evrysdi generics
The SMA drug is a growth driver for the Swiss pharma giant, prompting the company to prioritize its defense against potential generics.
Zoey Becker
Nov 20, 2024 9:44am
Novo settles with Mylan over potential Ozempic generic
Oct 7, 2024 9:18am
The FDA serves up warning letters to pair of Indian pharmas
Apr 10, 2024 9:58am
AstraZeneca, Takeda, BioNTech—Fierce Pharma Asia
Nov 10, 2023 8:05am
FDA slams Natco Pharma with Form 483 over sanitary, other issues
Nov 6, 2023 10:35am
BMS, generics companies face new suit over Revlimid 'monopoly'
Nov 22, 2022 11:38am
